Procter & Gamble Health Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Mar 2026 is 19.12% vs 23.17% in Mar 2025

Standalone Net Profit

YoY Growth in quarter ended Mar 2026 is 54.63% vs 31.40% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 67.56% vs 19.99% in Mar 2025

Interest

YoY Growth in quarter ended Mar 2026 is 61.54% vs -13.33% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of P & G Health Ltd With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

370.45

353.09

17.36

4.92%

Other Operating Income

0.00

Total Operating income

370.45

353.09

17.36

4.92%

Raw Material Cost

85.19

27.73

57.46

207.21%

Purchase of Finished goods

22.31

46.34

-24.03

-51.86%

(Increase) / Decrease In Stocks

-14.63

-7.83

-6.80

-86.85%

Employee Cost

50.86

106.63

-55.77

-52.30%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

91.13

118.20

-27.07

-22.90%

Total Expenditure (Excl Depreciation)

234.86

291.07

-56.21

-19.31%

Operating Profit (PBDIT) excl Other Income

135.59

62.02

73.57

118.62%

Other Income

4.00

4.11

-0.11

-2.68%

Operating Profit (PBDIT)

139.59

66.13

73.46

111.08%

Interest

0.21

1.38

-1.17

-84.78%

Exceptional Items

0.00

Gross Profit (PBDT)

139.38

64.75

74.63

115.26%

Depreciation

6.17

10.29

-4.12

-40.04%

Profit Before Tax

133.21

54.46

78.75

144.60%

Tax

38.61

9.41

29.20

310.31%

Provisions and contingencies

0.00

Profit After Tax

94.60

45.05

49.55

109.99%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

94.60

45.05

49.55

109.99%

Equity Capital

16.60

61.16

-44.56

-72.86%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

56.99

7.37

49.62

673.27%

Diluted Earnings per share

56.99

7.37

49.62

673.27%

Operating Profit Margin (Excl OI)

36.60%

17.56%

0.00

19.04%

Gross Profit Margin

37.62%

18.34%

0.00

19.28%

PAT Margin

25.54%

12.76%

0.00

12.78%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 370.45 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -0.91% vs 15.06% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 19.12% vs 23.17% in Mar 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 94.60 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 21.92% vs -12.37% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 54.63% vs 31.40% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 135.59 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 22.75% vs -8.16% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 67.56% vs 19.99% in Mar 2025

Quarterly - Interest

Interest 0.21 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 110.00% vs -16.67% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 61.54% vs -13.33% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 36.60%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025